Long‐term exposure to the new nicotinic antagonist 1,2‐bis<i>N</i>‐cytisinylethane upregulates nicotinic receptor subtypes of SH‐SY5Y human neuroblastoma cells
Loredana Riganti(Neuroscience Institute), Cecilia Gotti(Istituto Nazionale di Fisica Nucleare, Sezione di Milano Bicocca)
Cited by 26
Related Papers
Acid sphingomyelinase activity triggers microparticle release from glial cells
|The EMBO Journal|2009|586
α9‐ and α7‐containing receptors mediate the pro‐proliferative effects of nicotine in the A549 adenocarcinoma cell line
|British Journal of Pharmacology|2017|75
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment
|Journal of Neuroscience|2016|74
Expression of the α7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS
|Journal of Neuroimmunology|2010|59
Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors
|Pharmacological Research|2020|54